Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Therapeutic Advances in Medical Oncology
|
December 3, 2025
Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact
Marine Lejeune, Eric Wasielewski, Vincent Leroy, et al.
Therapeutic Advances in Medical Oncology
|
February 12, 2025
Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer
Amytis Roboubi, Eric Wasielewski, Soraya Bordier, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC
Ferréol Roborel de Climens, Christos Chouaid, Claire Poulet, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 19, 2019
Erratum to "Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases" [Lung Cancer 116 (February 2018) 62-66]
Clément Gauvain, Enora Vauléon, Christos Chouaid, et al.
COPD
|
May 5, 2015
Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience
Clément Gauvain, Jean-François Mornex, Christophe Pison, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 8, 2018
Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases
Clément Gauvain, Enora Vauléon, Christos Chouaid, et al.
Chest
|
February 3, 2016
Airway-Centered Fibroelastosis: A Distinct Entity
Pauline Pradere, Clément Gauvain, Claire Danel, et al.
Chest
|
March 16, 2019
Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension
Vincent Bunel, Alice Guyard, Gaëlle Dauriat, et al.
Targeted Oncology
|
November 3, 2023
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers
Marine Marchal, Vincent Leroy, Hélène Behal, et al.
Therapeutic Advances in Medical Oncology
|
September 18, 2023
Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer
Camille Ardin, Sarah Humez, Vincent Leroy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Therapeutic Advances in Medical Oncology
|
December 3, 2025
Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact
Marine Lejeune, Eric Wasielewski, Vincent Leroy, et al.
Therapeutic Advances in Medical Oncology
|
February 12, 2025
Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer
Amytis Roboubi, Eric Wasielewski, Soraya Bordier, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC
Ferréol Roborel de Climens, Christos Chouaid, Claire Poulet, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 19, 2019
Erratum to "Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases" [Lung Cancer 116 (February 2018) 62-66]
Clément Gauvain, Enora Vauléon, Christos Chouaid, et al.
COPD
|
May 5, 2015
Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience
Clément Gauvain, Jean-François Mornex, Christophe Pison, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 8, 2018
Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases
Clément Gauvain, Enora Vauléon, Christos Chouaid, et al.
Chest
|
February 3, 2016
Airway-Centered Fibroelastosis: A Distinct Entity
Pauline Pradere, Clément Gauvain, Claire Danel, et al.
Chest
|
March 16, 2019
Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension
Vincent Bunel, Alice Guyard, Gaëlle Dauriat, et al.
Targeted Oncology
|
November 3, 2023
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers
Marine Marchal, Vincent Leroy, Hélène Behal, et al.
Therapeutic Advances in Medical Oncology
|
September 18, 2023
Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer
Camille Ardin, Sarah Humez, Vincent Leroy, et al.
Page
of 2